Review



mouse monoclonal antibody against cd31  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Proteintech mouse monoclonal antibody against cd31
    A Left: representative immunofluorescence confocal microscopy showing the endothelial cell marker <t>CD31</t> (red) and the mesenchymal cell marker α smooth muscle actin (α-SMA) (green) in human umbilical vein endothelial cells (HUVEC) treated with cytokines (10 mg/μL transforming growth factor β [TGF-β1] and 1 ng/μL interleukin-1β [IL-1β]), expressing exogenous NOTCH1 intracellular domain (NICD1), or mitoNICD1 in low-power field (LPF) (10×) (top, scale bar=200 μm) and high-power field (HPF) (×40) (bottom, scale bar = 50 μm)). Nuclei are stained with DAPI (blue). Right: Quantification of α-SMA positive (α-SMA + ) cells per LPF ( n = 5 biological samples per group). B Representative western blot illustrating endothelial cell markers, including CD31, vascular endothelial cadherin (VE-Cad), and vascular endothelial growth factor receptor (VEGFR), and mesenchymal cell markers, including α-SMA, N-Cadherin (N-Cad), Vimentin, and Actin, in HUVEC expressing exogenous NICD1, mitoNICD1, or not. C Representative western blot illustrating the phosphorylation of pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1) (p-PDHA1) at serine 293 (Ser293) in HUVEC treated with PDH-activator dichloroacetate (DCA) (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PDH inhibitor PS-48 (100 μmol/L) as well. D Top: profile of oxygen consumption rate (OCR) of HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well. Bottom: Quantification of basal respiration and maximal respiration indicated by OCR ( n = 3 biological samples per group). E Left: representative immunofluorescence confocal microscopy showing CD31 (red) and α-SMA (green) in HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well (Scale bar=200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). F Representative immunofluorescence confocal microscopy of CD31 (red) and α-SMA (green) in HUVEC treated with 5, 10, or 20 mmol/L DCA (Scale bar = 200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). Source data are provided as a Source Data file. For A , D – F , data are presented as mean values ± SD; P values were calculated by unpaired Student’s t test with two-tailed analysis without adjustments.
    Mouse Monoclonal Antibody Against Cd31, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 83 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/PE+Anti-mouse+CD31/pmc11569218-310-26-33
    Average 95 stars, based on 83 article reviews
    mouse monoclonal antibody against cd31 - by Bioz Stars, 2026-10
    95/100 stars

    Images

    1) Product Images from "NOTCH1 mitochondria localization during heart development promotes mitochondrial metabolism and the endothelial-to-mesenchymal transition in mice"

    Article Title: NOTCH1 mitochondria localization during heart development promotes mitochondrial metabolism and the endothelial-to-mesenchymal transition in mice

    Journal: Nature Communications

    doi: 10.1038/s41467-024-54407-7

    A Left: representative immunofluorescence confocal microscopy showing the endothelial cell marker CD31 (red) and the mesenchymal cell marker α smooth muscle actin (α-SMA) (green) in human umbilical vein endothelial cells (HUVEC) treated with cytokines (10 mg/μL transforming growth factor β [TGF-β1] and 1 ng/μL interleukin-1β [IL-1β]), expressing exogenous NOTCH1 intracellular domain (NICD1), or mitoNICD1 in low-power field (LPF) (10×) (top, scale bar=200 μm) and high-power field (HPF) (×40) (bottom, scale bar = 50 μm)). Nuclei are stained with DAPI (blue). Right: Quantification of α-SMA positive (α-SMA + ) cells per LPF ( n = 5 biological samples per group). B Representative western blot illustrating endothelial cell markers, including CD31, vascular endothelial cadherin (VE-Cad), and vascular endothelial growth factor receptor (VEGFR), and mesenchymal cell markers, including α-SMA, N-Cadherin (N-Cad), Vimentin, and Actin, in HUVEC expressing exogenous NICD1, mitoNICD1, or not. C Representative western blot illustrating the phosphorylation of pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1) (p-PDHA1) at serine 293 (Ser293) in HUVEC treated with PDH-activator dichloroacetate (DCA) (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PDH inhibitor PS-48 (100 μmol/L) as well. D Top: profile of oxygen consumption rate (OCR) of HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well. Bottom: Quantification of basal respiration and maximal respiration indicated by OCR ( n = 3 biological samples per group). E Left: representative immunofluorescence confocal microscopy showing CD31 (red) and α-SMA (green) in HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well (Scale bar=200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). F Representative immunofluorescence confocal microscopy of CD31 (red) and α-SMA (green) in HUVEC treated with 5, 10, or 20 mmol/L DCA (Scale bar = 200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). Source data are provided as a Source Data file. For A , D – F , data are presented as mean values ± SD; P values were calculated by unpaired Student’s t test with two-tailed analysis without adjustments.
    Figure Legend Snippet: A Left: representative immunofluorescence confocal microscopy showing the endothelial cell marker CD31 (red) and the mesenchymal cell marker α smooth muscle actin (α-SMA) (green) in human umbilical vein endothelial cells (HUVEC) treated with cytokines (10 mg/μL transforming growth factor β [TGF-β1] and 1 ng/μL interleukin-1β [IL-1β]), expressing exogenous NOTCH1 intracellular domain (NICD1), or mitoNICD1 in low-power field (LPF) (10×) (top, scale bar=200 μm) and high-power field (HPF) (×40) (bottom, scale bar = 50 μm)). Nuclei are stained with DAPI (blue). Right: Quantification of α-SMA positive (α-SMA + ) cells per LPF ( n = 5 biological samples per group). B Representative western blot illustrating endothelial cell markers, including CD31, vascular endothelial cadherin (VE-Cad), and vascular endothelial growth factor receptor (VEGFR), and mesenchymal cell markers, including α-SMA, N-Cadherin (N-Cad), Vimentin, and Actin, in HUVEC expressing exogenous NICD1, mitoNICD1, or not. C Representative western blot illustrating the phosphorylation of pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1) (p-PDHA1) at serine 293 (Ser293) in HUVEC treated with PDH-activator dichloroacetate (DCA) (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PDH inhibitor PS-48 (100 μmol/L) as well. D Top: profile of oxygen consumption rate (OCR) of HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well. Bottom: Quantification of basal respiration and maximal respiration indicated by OCR ( n = 3 biological samples per group). E Left: representative immunofluorescence confocal microscopy showing CD31 (red) and α-SMA (green) in HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well (Scale bar=200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). F Representative immunofluorescence confocal microscopy of CD31 (red) and α-SMA (green) in HUVEC treated with 5, 10, or 20 mmol/L DCA (Scale bar = 200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). Source data are provided as a Source Data file. For A , D – F , data are presented as mean values ± SD; P values were calculated by unpaired Student’s t test with two-tailed analysis without adjustments.

    Techniques Used: Immunofluorescence, Confocal Microscopy, Marker, Expressing, Staining, Western Blot, Phospho-proteomics, Two Tailed Test

    Related Articles

    Incubation:

    Article Title: Exosomal Myeloperoxidase as a Biomarker of Deep Venous Thrombosis
    Article Snippet: Immuno uorescence For immuno uorescence staining, tissues were xed with 4% paraformaldehyde, and antigen repair was achieved by incubation with 0.25% citrate (ShiFeng Biology, Shanghai, China) for 16 h at 60°C. .. Sectioned tissues were blocked with goat serum at room temperature for 0.5 h before incubation overnight at 4°C with the following primary antibodies (1:500): mouse monoclonal antibody against CD31 (Proteintech) and rabbit monoclonal antibody against MPO (Proteintech). .. Sections were incubated for 1 h at room temperature with uorescently labeled anti-rabbit or anti-mouse secondary antibody (1:1000, Invitrogen).

    Article Title: Exosomal myeloperoxidase as a biomarker of deep venous thrombosis
    Article Snippet: Immunofluorescence For immunofluorescence staining, tissues were fixed with 4% paraformaldehyde, and antigen repair was achieved by incubation with 0.25% citrate (ShiFeng Biology, Shanghai, China) for 16 h at 60 °C. .. Sectioned tissues were blocked with goat serum at room temperature for 0.5 h before incubation overnight at 4 °C with the following primary antibodies (1:500): mouse monoclonal antibody against CD31 (Proteintech) and rabbit monoclonal antibody against MPO (Proteintech). .. Sections were incubated for 1 h at room temperature with fluorescently labeled anti-rabbit or anti-mouse secondary antibody (1:1,000, Invitrogen).

    Article Title: NOTCH1 mitochondria localization during heart development promotes mitochondrial metabolism and the endothelial-to-mesenchymal transition in mice
    Article Snippet: After washing with PBS, cells were incubated with Alexa 488-conjugated goat anti-rabbit antibody (A21206, Invitrogen) at 1:1,000 for 1 h. Cells were counterstained with DAPI for 5 min. Fluorescent optical images were captured using a Zeiss LSM880 confocal microscope and processed using ZEN software. .. To assess the expression of CD31 and α-SMA in EndMT assays, fixed and blocked HUVEC cells were stained with rabbit polyclonal antibody against α-SMA (1:200) and mouse monoclonal antibody against CD31 (1:200, #3528, Proteintech) overnight and incubated with Alexa 488-conjugated goat anti-rabbit antibody and Alexa 594-conjugated goat anti-mouse antibody (A11032, Invitrogen) at 1:1,000, following the abovementioned procedures. ..

    Article Title: Exosomal myeloperoxidase as a biomarker of deep venous thrombosis.
    Article Snippet: Immunofluorescence For immunofluorescence staining, tissues were fixed with 4% paraformaldehyde, and antigen repair was achieved by incubation with 0.25% citrate (ShiFeng Biology, Shanghai, China) for 16 h at 60 °C. .. Sectioned tissues were blocked with goat serum at room temperature for 0.5 h before incubation overnight at 4 °C with the following primary antibodies (1:500): mouse monoclonal antibody against CD31 (Proteintech) and rabbit monoclonal antibody against MPO (Proteintech). .. Sections were incubated for 1 h at room temperature with fluorescently labeled anti-rabbit or anti-mouse secondary antibody (1:1,000, Invitrogen).

    Expressing:

    Article Title: NOTCH1 mitochondria localization during heart development promotes mitochondrial metabolism and the endothelial-to-mesenchymal transition in mice
    Article Snippet: After washing with PBS, cells were incubated with Alexa 488-conjugated goat anti-rabbit antibody (A21206, Invitrogen) at 1:1,000 for 1 h. Cells were counterstained with DAPI for 5 min. Fluorescent optical images were captured using a Zeiss LSM880 confocal microscope and processed using ZEN software. .. To assess the expression of CD31 and α-SMA in EndMT assays, fixed and blocked HUVEC cells were stained with rabbit polyclonal antibody against α-SMA (1:200) and mouse monoclonal antibody against CD31 (1:200, #3528, Proteintech) overnight and incubated with Alexa 488-conjugated goat anti-rabbit antibody and Alexa 594-conjugated goat anti-mouse antibody (A11032, Invitrogen) at 1:1,000, following the abovementioned procedures. ..

    Staining:

    Article Title: NOTCH1 mitochondria localization during heart development promotes mitochondrial metabolism and the endothelial-to-mesenchymal transition in mice
    Article Snippet: After washing with PBS, cells were incubated with Alexa 488-conjugated goat anti-rabbit antibody (A21206, Invitrogen) at 1:1,000 for 1 h. Cells were counterstained with DAPI for 5 min. Fluorescent optical images were captured using a Zeiss LSM880 confocal microscope and processed using ZEN software. .. To assess the expression of CD31 and α-SMA in EndMT assays, fixed and blocked HUVEC cells were stained with rabbit polyclonal antibody against α-SMA (1:200) and mouse monoclonal antibody against CD31 (1:200, #3528, Proteintech) overnight and incubated with Alexa 488-conjugated goat anti-rabbit antibody and Alexa 594-conjugated goat anti-mouse antibody (A11032, Invitrogen) at 1:1,000, following the abovementioned procedures. ..



    Similar Products

    90
    Santa Cruz Biotechnology monoclonal antibody against mouse cd31
    Monoclonal Antibody Against Mouse Cd31, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/cd31+antibody/us12208120-64-18-23
    Average 90 stars, based on 1 article reviews
    monoclonal antibody against mouse cd31 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher mouse monoclonal antibody against human cd31
    Antibody details.
    Mouse Monoclonal Antibody Against Human Cd31, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/cd31+antibody/pmc11658613-1-2-9
    Average 90 stars, based on 1 article reviews
    mouse monoclonal antibody against human cd31 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    95
    Proteintech mouse monoclonal antibody against cd31
    A Left: representative immunofluorescence confocal microscopy showing the endothelial cell marker <t>CD31</t> (red) and the mesenchymal cell marker α smooth muscle actin (α-SMA) (green) in human umbilical vein endothelial cells (HUVEC) treated with cytokines (10 mg/μL transforming growth factor β [TGF-β1] and 1 ng/μL interleukin-1β [IL-1β]), expressing exogenous NOTCH1 intracellular domain (NICD1), or mitoNICD1 in low-power field (LPF) (10×) (top, scale bar=200 μm) and high-power field (HPF) (×40) (bottom, scale bar = 50 μm)). Nuclei are stained with DAPI (blue). Right: Quantification of α-SMA positive (α-SMA + ) cells per LPF ( n = 5 biological samples per group). B Representative western blot illustrating endothelial cell markers, including CD31, vascular endothelial cadherin (VE-Cad), and vascular endothelial growth factor receptor (VEGFR), and mesenchymal cell markers, including α-SMA, N-Cadherin (N-Cad), Vimentin, and Actin, in HUVEC expressing exogenous NICD1, mitoNICD1, or not. C Representative western blot illustrating the phosphorylation of pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1) (p-PDHA1) at serine 293 (Ser293) in HUVEC treated with PDH-activator dichloroacetate (DCA) (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PDH inhibitor PS-48 (100 μmol/L) as well. D Top: profile of oxygen consumption rate (OCR) of HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well. Bottom: Quantification of basal respiration and maximal respiration indicated by OCR ( n = 3 biological samples per group). E Left: representative immunofluorescence confocal microscopy showing CD31 (red) and α-SMA (green) in HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well (Scale bar=200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). F Representative immunofluorescence confocal microscopy of CD31 (red) and α-SMA (green) in HUVEC treated with 5, 10, or 20 mmol/L DCA (Scale bar = 200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). Source data are provided as a Source Data file. For A , D – F , data are presented as mean values ± SD; P values were calculated by unpaired Student’s t test with two-tailed analysis without adjustments.
    Mouse Monoclonal Antibody Against Cd31, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/PE+Anti-mouse+CD31/pmc11569218-310-26-33
    Average 95 stars, based on 1 article reviews
    mouse monoclonal antibody against cd31 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    90
    Biozol Diagnostica Vertrieb GmbH monoclonal rat anti-mouse antibody against endothelial cell marker cd31
    ( a – d ) Representative histological images of TRAP-positive osteoclasts (arrowheads) within callus tissue of wildtype ( a , b ) and Nlrp3 −/− mice ( c , d ) at 2 ( a , c ) and 5 weeks ( b , d ) after fracture. Scale bars 50 µm. ( e – h ) Representative immunohistochemical images of <t>CD31-positive</t> microvessels (arrowheads) within the callus tissue of wildtype ( e , f ) and Nlrp3 −/− mice ( g , h ) at 2 ( e , g ) and 5 weeks ( f , h ) after fracture. Scale bars: 50 µm. Histological analysis of TRAP-positive osteoclasts/HPF ( i ) and immunohistochemical analysis of CD31-positive microvessels/HPF ( j ) within callus tissue of wildtype (white bars, n = 8) and Nlrp3 −/− mice (black bars, n = 9–10) at 2 and 5 weeks after fracture (mean ± SEM). * p < 0.05 vs. wildtype.
    Monoclonal Rat Anti Mouse Antibody Against Endothelial Cell Marker Cd31, supplied by Biozol Diagnostica Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/cd31+antibody/pmc11546854-140-12-22
    Average 90 stars, based on 1 article reviews
    monoclonal rat anti-mouse antibody against endothelial cell marker cd31 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    94
    Bio-Rad rat monoclonal antibody against cd3ε
    Fig. 3 Assessment of tumor infiltrating lymphocytes in canine MCTs. Correlative analyses of transcriptional T cell score with A. ICOSLG and B. PDCD1 transcripts (each dot represents an individual dog using log2 normalized expression of transcripts). Comparisons of C. transcriptional T cell score D. and density of <t>CD3</t> + T cells determined immunohistochemically between low and high grade MCTs (mean and standard deviations displayed). Images of lymphoid aggregates consistent with tertiary lymphoid structures within the high grade MCT-12 using E. immunohistochemical staining against CD3 (DAB chromogen reaction and hematoxylin counterstain) and F. co-immunofluorescent labelling of CD3 (green), CD79b (red), KIT (white), nuclear DAPI (blue) labelling. (Scale bars = 200 μm. DAB- diaminobenzidine; DAPI- 4’,6’-diamidino-2-phenylinlindole. Correlative analyses performed using two-tailed Spearman correlation Spearman rho (rs) and p values displayed. Comparisons between two groups performed using two-tailed Mann–Whitney tests, ns = not significant.)
    Rat Monoclonal Antibody Against Cd3ε, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/Mouse+anti+Rat+CD31/pm40093350-91-2-8
    Average 94 stars, based on 1 article reviews
    rat monoclonal antibody against cd3ε - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    90
    Novus Biologicals rat monoclonal antibody conjugated with dylight-488 fluorochrome against mouse cd31/pecam-1
    Fig. 3 Assessment of tumor infiltrating lymphocytes in canine MCTs. Correlative analyses of transcriptional T cell score with A. ICOSLG and B. PDCD1 transcripts (each dot represents an individual dog using log2 normalized expression of transcripts). Comparisons of C. transcriptional T cell score D. and density of <t>CD3</t> + T cells determined immunohistochemically between low and high grade MCTs (mean and standard deviations displayed). Images of lymphoid aggregates consistent with tertiary lymphoid structures within the high grade MCT-12 using E. immunohistochemical staining against CD3 (DAB chromogen reaction and hematoxylin counterstain) and F. co-immunofluorescent labelling of CD3 (green), CD79b (red), KIT (white), nuclear DAPI (blue) labelling. (Scale bars = 200 μm. DAB- diaminobenzidine; DAPI- 4’,6’-diamidino-2-phenylinlindole. Correlative analyses performed using two-tailed Spearman correlation Spearman rho (rs) and p values displayed. Comparisons between two groups performed using two-tailed Mann–Whitney tests, ns = not significant.)
    Rat Monoclonal Antibody Conjugated With Dylight 488 Fluorochrome Against Mouse Cd31/Pecam 1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/cd31+antibody/pmc11506673-136-30-43
    Average 90 stars, based on 1 article reviews
    rat monoclonal antibody conjugated with dylight-488 fluorochrome against mouse cd31/pecam-1 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher mouse monoclonal antibody against rat cd31
    Fig. 3 Assessment of tumor infiltrating lymphocytes in canine MCTs. Correlative analyses of transcriptional T cell score with A. ICOSLG and B. PDCD1 transcripts (each dot represents an individual dog using log2 normalized expression of transcripts). Comparisons of C. transcriptional T cell score D. and density of <t>CD3</t> + T cells determined immunohistochemically between low and high grade MCTs (mean and standard deviations displayed). Images of lymphoid aggregates consistent with tertiary lymphoid structures within the high grade MCT-12 using E. immunohistochemical staining against CD3 (DAB chromogen reaction and hematoxylin counterstain) and F. co-immunofluorescent labelling of CD3 (green), CD79b (red), KIT (white), nuclear DAPI (blue) labelling. (Scale bars = 200 μm. DAB- diaminobenzidine; DAPI- 4’,6’-diamidino-2-phenylinlindole. Correlative analyses performed using two-tailed Spearman correlation Spearman rho (rs) and p values displayed. Comparisons between two groups performed using two-tailed Mann–Whitney tests, ns = not significant.)
    Mouse Monoclonal Antibody Against Rat Cd31, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/cd31+antibody/pm38719089-82-7-13
    Average 90 stars, based on 1 article reviews
    mouse monoclonal antibody against rat cd31 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    92
    OriGene primary antibodies against cd31
    Figure 8. Expression of <t>CD31</t> and human nuclei. (A) Paraffin sections of skin lesions from autologous skin transplantation for 1 week were obtained, and the endothelial cells CD31 and human nuclei were stained by immunohistochemistry. Scale bars: 100 μm (upper row), 20 μm (lower row). (B) Quantification of CD31-positive expression. hPMSCs: human placenta-derived mesenchymal stem cells.
    Primary Antibodies Against Cd31, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/CD31+(PECAM1)+Mouse+Monoclonal+Antibody/pm38334047-81-12-17
    Average 92 stars, based on 1 article reviews
    primary antibodies against cd31 - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    90
    Biozol Diagnostica Vertrieb GmbH monoclonal rat anti-mouse antibody against cd31
    Histomorphology of subcutaneous adipose tissue from lean and obese mice. A , B HE-stained sections of the subcutaneous adipose tissue from a lean ( A ) and an obese ( B ) mouse. Scale bars: 30 µm. C , D Adipocyte diameter ( C , given in µm) and adipocyte density ( D , given in mm −2 ) within the subcutaneous adipose tissue from lean (white bars, n = 5) and obese (black bars, n = 5) mice. Means ± SEM. * p < 0.05 versus lean. E , F Sirius red-stained sections under polarized light, displaying larger blood vessels (arrows) with surrounding type I collagen within the subcutaneous adipose tissue from a lean ( E ) and an obese ( F ) mouse Scale bars: 40 µm. G Collagen fraction (given in % of adipose tissue) within the subcutaneous adipose tissue from lean (white bar, n = 5) and obese (black bar, n = 5) mice. Means ± SEM. * p < 0.05 vs. lean. H , I Immunohistochemical detection of <t>CD31</t> + microvessels (arrows) between adipocytes (asterisks) within the subcutaneous adipose tissue from a lean ( H ) and an obese ( I ) mouse. Cell nuclei were stained with Hoechst 33342. Scale bars: 15 µm. J Microvessel density (given in mm −2 ) within the subcutaneous adipose tissue from lean (white bar, n = 5) and obese (black bar, n = 5) mice. Means ± SEM. * p < 0.05 versus lean
    Monoclonal Rat Anti Mouse Antibody Against Cd31, supplied by Biozol Diagnostica Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/cd31+antibody/pmc10645785-85-7-14
    Average 90 stars, based on 1 article reviews
    monoclonal rat anti-mouse antibody against cd31 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    99
    Danaher Inc mouse monoclonal antibody against human cd31
    Adoptively transferred CAR133-i502-NK92 cells successfully control tumor development in mice with CD133+ and CD133− mixed colon tumor models. (A) Schedule of the in vivo experimental design using CD133+ and CD133- mixed colon tumor model. (B) BLI illustrating colon cancer growth. (C) Kaplan–Meier survival curves generated from the survival of mice treated with CAR133-i502-NK92 and CAR133-NK92 cells. *** P < 0.001. (D) Expression of <t>CD31</t> protein was tested in the mouse tumor tissue using IHC assays. Representative photomicrographs are shown (magnification ×400). The scale bar is 50 μm. *** P < 0.001. (E) Representative immunostaining images of CD3+ T-cell infiltration into cancer tissues. Representative staining of tumor sections in each experimental group is shown (magnification ×400). The scale bar represents 50 μm. *** P < 0.001.
    Mouse Monoclonal Antibody Against Human Cd31, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+cd31/mouse+monoclonal+Anti-SOX2+antibody/pmc10546094-132-30-36
    Average 99 stars, based on 1 article reviews
    mouse monoclonal antibody against human cd31 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results


    Antibody details.

    Journal: PLOS ONE

    Article Title: Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich’s Ascites Carcinoma: Role of Angiotensin (1–7)

    doi: 10.1371/journal.pone.0316407

    Figure Lengend Snippet: Antibody details.

    Article Snippet: CD31 , Mouse monoclonal antibody against human CD31 , Thermo Fisher Scientific (Fremont, USA). , #MS-353-R7.

    Techniques:

    A Left: representative immunofluorescence confocal microscopy showing the endothelial cell marker CD31 (red) and the mesenchymal cell marker α smooth muscle actin (α-SMA) (green) in human umbilical vein endothelial cells (HUVEC) treated with cytokines (10 mg/μL transforming growth factor β [TGF-β1] and 1 ng/μL interleukin-1β [IL-1β]), expressing exogenous NOTCH1 intracellular domain (NICD1), or mitoNICD1 in low-power field (LPF) (10×) (top, scale bar=200 μm) and high-power field (HPF) (×40) (bottom, scale bar = 50 μm)). Nuclei are stained with DAPI (blue). Right: Quantification of α-SMA positive (α-SMA + ) cells per LPF ( n = 5 biological samples per group). B Representative western blot illustrating endothelial cell markers, including CD31, vascular endothelial cadherin (VE-Cad), and vascular endothelial growth factor receptor (VEGFR), and mesenchymal cell markers, including α-SMA, N-Cadherin (N-Cad), Vimentin, and Actin, in HUVEC expressing exogenous NICD1, mitoNICD1, or not. C Representative western blot illustrating the phosphorylation of pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1) (p-PDHA1) at serine 293 (Ser293) in HUVEC treated with PDH-activator dichloroacetate (DCA) (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PDH inhibitor PS-48 (100 μmol/L) as well. D Top: profile of oxygen consumption rate (OCR) of HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well. Bottom: Quantification of basal respiration and maximal respiration indicated by OCR ( n = 3 biological samples per group). E Left: representative immunofluorescence confocal microscopy showing CD31 (red) and α-SMA (green) in HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well (Scale bar=200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). F Representative immunofluorescence confocal microscopy of CD31 (red) and α-SMA (green) in HUVEC treated with 5, 10, or 20 mmol/L DCA (Scale bar = 200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). Source data are provided as a Source Data file. For A , D – F , data are presented as mean values ± SD; P values were calculated by unpaired Student’s t test with two-tailed analysis without adjustments.

    Journal: Nature Communications

    Article Title: NOTCH1 mitochondria localization during heart development promotes mitochondrial metabolism and the endothelial-to-mesenchymal transition in mice

    doi: 10.1038/s41467-024-54407-7

    Figure Lengend Snippet: A Left: representative immunofluorescence confocal microscopy showing the endothelial cell marker CD31 (red) and the mesenchymal cell marker α smooth muscle actin (α-SMA) (green) in human umbilical vein endothelial cells (HUVEC) treated with cytokines (10 mg/μL transforming growth factor β [TGF-β1] and 1 ng/μL interleukin-1β [IL-1β]), expressing exogenous NOTCH1 intracellular domain (NICD1), or mitoNICD1 in low-power field (LPF) (10×) (top, scale bar=200 μm) and high-power field (HPF) (×40) (bottom, scale bar = 50 μm)). Nuclei are stained with DAPI (blue). Right: Quantification of α-SMA positive (α-SMA + ) cells per LPF ( n = 5 biological samples per group). B Representative western blot illustrating endothelial cell markers, including CD31, vascular endothelial cadherin (VE-Cad), and vascular endothelial growth factor receptor (VEGFR), and mesenchymal cell markers, including α-SMA, N-Cadherin (N-Cad), Vimentin, and Actin, in HUVEC expressing exogenous NICD1, mitoNICD1, or not. C Representative western blot illustrating the phosphorylation of pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1) (p-PDHA1) at serine 293 (Ser293) in HUVEC treated with PDH-activator dichloroacetate (DCA) (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PDH inhibitor PS-48 (100 μmol/L) as well. D Top: profile of oxygen consumption rate (OCR) of HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well. Bottom: Quantification of basal respiration and maximal respiration indicated by OCR ( n = 3 biological samples per group). E Left: representative immunofluorescence confocal microscopy showing CD31 (red) and α-SMA (green) in HUVEC treated with DCA (10 mmol/L), expressing mitoNICD1, or expressing mitoNICD1 and supplemented with PS-48 (100 μmol/L) as well (Scale bar=200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). F Representative immunofluorescence confocal microscopy of CD31 (red) and α-SMA (green) in HUVEC treated with 5, 10, or 20 mmol/L DCA (Scale bar = 200 μm). Right: quantification of α-SMA + cells per LPF ( n = 5 biological samples per group). Source data are provided as a Source Data file. For A , D – F , data are presented as mean values ± SD; P values were calculated by unpaired Student’s t test with two-tailed analysis without adjustments.

    Article Snippet: To assess the expression of CD31 and α-SMA in EndMT assays, fixed and blocked HUVEC cells were stained with rabbit polyclonal antibody against α-SMA (1:200) and mouse monoclonal antibody against CD31 (1:200, #3528, Proteintech) overnight and incubated with Alexa 488-conjugated goat anti-rabbit antibody and Alexa 594-conjugated goat anti-mouse antibody (A11032, Invitrogen) at 1:1,000, following the abovementioned procedures.

    Techniques: Immunofluorescence, Confocal Microscopy, Marker, Expressing, Staining, Western Blot, Phospho-proteomics, Two Tailed Test

    ( a – d ) Representative histological images of TRAP-positive osteoclasts (arrowheads) within callus tissue of wildtype ( a , b ) and Nlrp3 −/− mice ( c , d ) at 2 ( a , c ) and 5 weeks ( b , d ) after fracture. Scale bars 50 µm. ( e – h ) Representative immunohistochemical images of CD31-positive microvessels (arrowheads) within the callus tissue of wildtype ( e , f ) and Nlrp3 −/− mice ( g , h ) at 2 ( e , g ) and 5 weeks ( f , h ) after fracture. Scale bars: 50 µm. Histological analysis of TRAP-positive osteoclasts/HPF ( i ) and immunohistochemical analysis of CD31-positive microvessels/HPF ( j ) within callus tissue of wildtype (white bars, n = 8) and Nlrp3 −/− mice (black bars, n = 9–10) at 2 and 5 weeks after fracture (mean ± SEM). * p < 0.05 vs. wildtype.

    Journal: International Journal of Molecular Sciences

    Article Title: Nlrp3 Deficiency Does Not Substantially Affect Femoral Fracture Healing in Mice

    doi: 10.3390/ijms252111788

    Figure Lengend Snippet: ( a – d ) Representative histological images of TRAP-positive osteoclasts (arrowheads) within callus tissue of wildtype ( a , b ) and Nlrp3 −/− mice ( c , d ) at 2 ( a , c ) and 5 weeks ( b , d ) after fracture. Scale bars 50 µm. ( e – h ) Representative immunohistochemical images of CD31-positive microvessels (arrowheads) within the callus tissue of wildtype ( e , f ) and Nlrp3 −/− mice ( g , h ) at 2 ( e , g ) and 5 weeks ( f , h ) after fracture. Scale bars: 50 µm. Histological analysis of TRAP-positive osteoclasts/HPF ( i ) and immunohistochemical analysis of CD31-positive microvessels/HPF ( j ) within callus tissue of wildtype (white bars, n = 8) and Nlrp3 −/− mice (black bars, n = 9–10) at 2 and 5 weeks after fracture (mean ± SEM). * p < 0.05 vs. wildtype.

    Article Snippet: For the immunohistochemical detection of microvessels, the sections were stained with a monoclonal rat anti-mouse antibody against endothelial cell marker CD31 (1:100; Dianova, Hamburg, Germany).

    Techniques: Immunohistochemical staining

    Fig. 3 Assessment of tumor infiltrating lymphocytes in canine MCTs. Correlative analyses of transcriptional T cell score with A. ICOSLG and B. PDCD1 transcripts (each dot represents an individual dog using log2 normalized expression of transcripts). Comparisons of C. transcriptional T cell score D. and density of CD3 + T cells determined immunohistochemically between low and high grade MCTs (mean and standard deviations displayed). Images of lymphoid aggregates consistent with tertiary lymphoid structures within the high grade MCT-12 using E. immunohistochemical staining against CD3 (DAB chromogen reaction and hematoxylin counterstain) and F. co-immunofluorescent labelling of CD3 (green), CD79b (red), KIT (white), nuclear DAPI (blue) labelling. (Scale bars = 200 μm. DAB- diaminobenzidine; DAPI- 4’,6’-diamidino-2-phenylinlindole. Correlative analyses performed using two-tailed Spearman correlation Spearman rho (rs) and p values displayed. Comparisons between two groups performed using two-tailed Mann–Whitney tests, ns = not significant.)

    Journal: Veterinary oncology (London, England)

    Article Title: Intertumoral heterogeneity of the immune microenvironment in high grade canine mast cell tumors.

    doi: 10.1186/s44356-025-00020-9

    Figure Lengend Snippet: Fig. 3 Assessment of tumor infiltrating lymphocytes in canine MCTs. Correlative analyses of transcriptional T cell score with A. ICOSLG and B. PDCD1 transcripts (each dot represents an individual dog using log2 normalized expression of transcripts). Comparisons of C. transcriptional T cell score D. and density of CD3 + T cells determined immunohistochemically between low and high grade MCTs (mean and standard deviations displayed). Images of lymphoid aggregates consistent with tertiary lymphoid structures within the high grade MCT-12 using E. immunohistochemical staining against CD3 (DAB chromogen reaction and hematoxylin counterstain) and F. co-immunofluorescent labelling of CD3 (green), CD79b (red), KIT (white), nuclear DAPI (blue) labelling. (Scale bars = 200 μm. DAB- diaminobenzidine; DAPI- 4’,6’-diamidino-2-phenylinlindole. Correlative analyses performed using two-tailed Spearman correlation Spearman rho (rs) and p values displayed. Comparisons between two groups performed using two-tailed Mann–Whitney tests, ns = not significant.)

    Article Snippet: A primary rat monoclonal antibody against CD3ε (CD3, Bio-Rad MCA1477T, clone CD312) was used at a concentration of 1/600 and incubated on the slides for 45 min at RT.

    Techniques: Expressing, Immunohistochemical staining, Staining, Two Tailed Test, MANN-WHITNEY

    Figure 8. Expression of CD31 and human nuclei. (A) Paraffin sections of skin lesions from autologous skin transplantation for 1 week were obtained, and the endothelial cells CD31 and human nuclei were stained by immunohistochemistry. Scale bars: 100 μm (upper row), 20 μm (lower row). (B) Quantification of CD31-positive expression. hPMSCs: human placenta-derived mesenchymal stem cells.

    Journal: Cell transplantation

    Article Title: Human Placenta-Derived Mesenchymal Stem Cells Combined With Artificial Dermal Scaffold Enhance Wound Healing in a Tendon-Exposed Wound of a Rabbit Model.

    doi: 10.1177/09636897241228922

    Figure Lengend Snippet: Figure 8. Expression of CD31 and human nuclei. (A) Paraffin sections of skin lesions from autologous skin transplantation for 1 week were obtained, and the endothelial cells CD31 and human nuclei were stained by immunohistochemistry. Scale bars: 100 μm (upper row), 20 μm (lower row). (B) Quantification of CD31-positive expression. hPMSCs: human placenta-derived mesenchymal stem cells.

    Article Snippet: After de-paraffinizing with xylene and rehydrating the sections (descending gradient of ethanol), primary antibodies against CD31 (1:1,000, OriGene, USA) or human nuclear antibody (1:500, Millipore, USA) were added at 4°C overnight, followed by incubation with horseradish peroxidaseconjugated affinipure goat anti-mouse immunoglobulin G (IgG) for 1 h at room temperature, followed by colorimetric detection using DAB (3,3′-diaminobenzidine) substrate, according to the manufacturer’s protocol20.

    Techniques: Expressing, Transplantation Assay, Staining, Immunohistochemistry, Derivative Assay

    Histomorphology of subcutaneous adipose tissue from lean and obese mice. A , B HE-stained sections of the subcutaneous adipose tissue from a lean ( A ) and an obese ( B ) mouse. Scale bars: 30 µm. C , D Adipocyte diameter ( C , given in µm) and adipocyte density ( D , given in mm −2 ) within the subcutaneous adipose tissue from lean (white bars, n = 5) and obese (black bars, n = 5) mice. Means ± SEM. * p < 0.05 versus lean. E , F Sirius red-stained sections under polarized light, displaying larger blood vessels (arrows) with surrounding type I collagen within the subcutaneous adipose tissue from a lean ( E ) and an obese ( F ) mouse Scale bars: 40 µm. G Collagen fraction (given in % of adipose tissue) within the subcutaneous adipose tissue from lean (white bar, n = 5) and obese (black bar, n = 5) mice. Means ± SEM. * p < 0.05 vs. lean. H , I Immunohistochemical detection of CD31 + microvessels (arrows) between adipocytes (asterisks) within the subcutaneous adipose tissue from a lean ( H ) and an obese ( I ) mouse. Cell nuclei were stained with Hoechst 33342. Scale bars: 15 µm. J Microvessel density (given in mm −2 ) within the subcutaneous adipose tissue from lean (white bar, n = 5) and obese (black bar, n = 5) mice. Means ± SEM. * p < 0.05 versus lean

    Journal: Tissue Engineering and Regenerative Medicine

    Article Title: Generation of Connective Tissue-Free Microvascular Fragment Isolates from Subcutaneous Fat Tissue of Obese Mice

    doi: 10.1007/s13770-023-00571-8

    Figure Lengend Snippet: Histomorphology of subcutaneous adipose tissue from lean and obese mice. A , B HE-stained sections of the subcutaneous adipose tissue from a lean ( A ) and an obese ( B ) mouse. Scale bars: 30 µm. C , D Adipocyte diameter ( C , given in µm) and adipocyte density ( D , given in mm −2 ) within the subcutaneous adipose tissue from lean (white bars, n = 5) and obese (black bars, n = 5) mice. Means ± SEM. * p < 0.05 versus lean. E , F Sirius red-stained sections under polarized light, displaying larger blood vessels (arrows) with surrounding type I collagen within the subcutaneous adipose tissue from a lean ( E ) and an obese ( F ) mouse Scale bars: 40 µm. G Collagen fraction (given in % of adipose tissue) within the subcutaneous adipose tissue from lean (white bar, n = 5) and obese (black bar, n = 5) mice. Means ± SEM. * p < 0.05 vs. lean. H , I Immunohistochemical detection of CD31 + microvessels (arrows) between adipocytes (asterisks) within the subcutaneous adipose tissue from a lean ( H ) and an obese ( I ) mouse. Cell nuclei were stained with Hoechst 33342. Scale bars: 15 µm. J Microvessel density (given in mm −2 ) within the subcutaneous adipose tissue from lean (white bar, n = 5) and obese (black bar, n = 5) mice. Means ± SEM. * p < 0.05 versus lean

    Article Snippet: For immunohistochemistry, sections were co-stained with a monoclonal rat anti-mouse antibody against CD31 (1:100; Dianova, Hamburg, Germany) and a polyclonal goat antibody against GFP (1:200; Rockland Immunochemicals, Limerick, PA, USA).

    Techniques: Staining, Immunohistochemistry

    Histomorphology of implanted MVF-seeded CGAG scaffolds. A , B HE-stained sections of CGAG scaffolds (borders marked by broken lines) seeded with MVF isolates from the subcutaneous adipose tissue of a lean ( A ) and an obese ( B ) mouse on day 14 after implantation into full-thickness skin defects within the dorsal skinfold chamber of recipient mice. Scale bars: 230 µm. C – E Sirius red-stained sections under polarized light of normal skin ( C ) as well as CGAG scaffolds seeded with MVF isolates from the subcutaneous adipose tissue of a lean ( D ) and an obese ( E ) mouse (arrows = collagen fibers). Scale bars: 12 µm. F Total collagen ratio (given as implant/skin) of CGAG scaffolds seeded with MVF isolates from the subcutaneous adipose tissue of lean (white bar, n = 10) and obese (black bar, n = 10) mice on day 14 after implantation into full-thickness skin defects within the dorsal skinfold chamber of recipient mice. Means ± SEM. G , H Immunohistochemical detection of CD31 + microvessels (arrows) within CGAG scaffolds seeded with MVF isolates from the subcutaneous adipose tissue of a lean ( G ) and an obese ( H ) mouse. Cell nuclei were stained with Hoechst 33342. Scale bars: 30 µm. I Microvessel density (given in mm −2 ) of CGAG scaffolds seeded with MVF isolates from the subcutaneous adipose tissue of lean (white bar, n = 10) and obese (black bar, n = 10) mice on day 14 after implantation into full-thickness skin defects within the dorsal skinfold chamber of recipient mice. Means ± SEM. * p < 0.05 versus lean. J – L Immunohistochemical detection of a CD31 + /GFP + microvessel (arrowhead) and a CD31 + /GFP − microvessel (arrow) within a CGAG scaffold seeded with an MVF isolate from the subcutaneous adipose tissue of a lean mouse. Cell nuclei were stained with Hoechst 33342. Scale bars: 20 µm. M CD31 + /GFP + microvessels (given in %) within CGAG scaffolds seeded with MVF isolates from the subcutaneous adipose tissue of lean (white bar, n = 10) and obese (black bar, n = 10) mice on day 14 after implantation into full-thickness skin defects within the dorsal skinfold chamber of recipient mice. Means ± SEM

    Journal: Tissue Engineering and Regenerative Medicine

    Article Title: Generation of Connective Tissue-Free Microvascular Fragment Isolates from Subcutaneous Fat Tissue of Obese Mice

    doi: 10.1007/s13770-023-00571-8

    Figure Lengend Snippet: Histomorphology of implanted MVF-seeded CGAG scaffolds. A , B HE-stained sections of CGAG scaffolds (borders marked by broken lines) seeded with MVF isolates from the subcutaneous adipose tissue of a lean ( A ) and an obese ( B ) mouse on day 14 after implantation into full-thickness skin defects within the dorsal skinfold chamber of recipient mice. Scale bars: 230 µm. C – E Sirius red-stained sections under polarized light of normal skin ( C ) as well as CGAG scaffolds seeded with MVF isolates from the subcutaneous adipose tissue of a lean ( D ) and an obese ( E ) mouse (arrows = collagen fibers). Scale bars: 12 µm. F Total collagen ratio (given as implant/skin) of CGAG scaffolds seeded with MVF isolates from the subcutaneous adipose tissue of lean (white bar, n = 10) and obese (black bar, n = 10) mice on day 14 after implantation into full-thickness skin defects within the dorsal skinfold chamber of recipient mice. Means ± SEM. G , H Immunohistochemical detection of CD31 + microvessels (arrows) within CGAG scaffolds seeded with MVF isolates from the subcutaneous adipose tissue of a lean ( G ) and an obese ( H ) mouse. Cell nuclei were stained with Hoechst 33342. Scale bars: 30 µm. I Microvessel density (given in mm −2 ) of CGAG scaffolds seeded with MVF isolates from the subcutaneous adipose tissue of lean (white bar, n = 10) and obese (black bar, n = 10) mice on day 14 after implantation into full-thickness skin defects within the dorsal skinfold chamber of recipient mice. Means ± SEM. * p < 0.05 versus lean. J – L Immunohistochemical detection of a CD31 + /GFP + microvessel (arrowhead) and a CD31 + /GFP − microvessel (arrow) within a CGAG scaffold seeded with an MVF isolate from the subcutaneous adipose tissue of a lean mouse. Cell nuclei were stained with Hoechst 33342. Scale bars: 20 µm. M CD31 + /GFP + microvessels (given in %) within CGAG scaffolds seeded with MVF isolates from the subcutaneous adipose tissue of lean (white bar, n = 10) and obese (black bar, n = 10) mice on day 14 after implantation into full-thickness skin defects within the dorsal skinfold chamber of recipient mice. Means ± SEM

    Article Snippet: For immunohistochemistry, sections were co-stained with a monoclonal rat anti-mouse antibody against CD31 (1:100; Dianova, Hamburg, Germany) and a polyclonal goat antibody against GFP (1:200; Rockland Immunochemicals, Limerick, PA, USA).

    Techniques: Staining, Immunohistochemistry

    Adoptively transferred CAR133-i502-NK92 cells successfully control tumor development in mice with CD133+ and CD133− mixed colon tumor models. (A) Schedule of the in vivo experimental design using CD133+ and CD133- mixed colon tumor model. (B) BLI illustrating colon cancer growth. (C) Kaplan–Meier survival curves generated from the survival of mice treated with CAR133-i502-NK92 and CAR133-NK92 cells. *** P < 0.001. (D) Expression of CD31 protein was tested in the mouse tumor tissue using IHC assays. Representative photomicrographs are shown (magnification ×400). The scale bar is 50 μm. *** P < 0.001. (E) Representative immunostaining images of CD3+ T-cell infiltration into cancer tissues. Representative staining of tumor sections in each experimental group is shown (magnification ×400). The scale bar represents 50 μm. *** P < 0.001.

    Journal: Cancer Biology & Medicine

    Article Title: The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer

    doi: 10.20892/j.issn.2095-3941.2023.0033

    Figure Lengend Snippet: Adoptively transferred CAR133-i502-NK92 cells successfully control tumor development in mice with CD133+ and CD133− mixed colon tumor models. (A) Schedule of the in vivo experimental design using CD133+ and CD133- mixed colon tumor model. (B) BLI illustrating colon cancer growth. (C) Kaplan–Meier survival curves generated from the survival of mice treated with CAR133-i502-NK92 and CAR133-NK92 cells. *** P < 0.001. (D) Expression of CD31 protein was tested in the mouse tumor tissue using IHC assays. Representative photomicrographs are shown (magnification ×400). The scale bar is 50 μm. *** P < 0.001. (E) Representative immunostaining images of CD3+ T-cell infiltration into cancer tissues. Representative staining of tumor sections in each experimental group is shown (magnification ×400). The scale bar represents 50 μm. *** P < 0.001.

    Article Snippet: Tumor tissue sections were stained for infiltration by human T cells using a mouse monoclonal antibody against human CD3ε (Thermo Scientific, Waltham, MA, USA) and for tumor angiogenesis using a mouse monoclonal antibody against human CD31 (Abcam).

    Techniques: Control, In Vivo, Generated, Expressing, Immunostaining, Staining